The loss of Seattle Genetics under GAAP for 6 months of 2020 amounted to $189.592 million, having doubled compared to $92.567 million in the previous year. Revenues increased by 23.9% to $512,512 million compared to $413,646 million a year earlier.
The loss of Seattle Genetics under GAAP for 6 months of 2020 amounted to $189.592 million, having doubled compared to $92.567 million in the previous year. Revenues increased by 23.9% to $512,512 million compared to $413,646 million a year earlier. 
investor.seattlegenetics.com
English (US) 